Risk assessment and risk management of transgenic pharmaplants

My name is Leticia Pastor Chirino, I am the Head of the Authorization Department of the National Center for Biosafety in Cuba. In the case of Cuba at this moment only one research involving Pharmaplants´ development has been authorized, this research is still in an early stage, with a small number of plants under confinement conditions (Green House).

The risk assessment and the risk management process in this case is not different from other processes but in our country the activities involving the obtaining of Pharmaplants is always done under confinement conditions and its use will be limited only for the obtaining of pharma products. The rest of the plants should be destroyed avoiding its use with other objectives.